![]() |
市场调查报告书
商品编码
1471306
萤光内视镜市场:按产品、焦点、应用和最终用户 - 2024-2030 年全球预测Fluorescence Endoscopy Market by Products (Accessories, Endoscope, Imaging System), Focusing (Electric, Manual), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年萤光内视镜市场规模为81.1亿美元,预计2024年将达87.2亿美元,2030年将达到138.2亿美元,复合年增长率为7.90%。
萤光内视镜是一种微创成像技术,用于评估器官健康、诊断疾病和检测癌细胞。由于几个重要因素,萤光内视镜已成为各种医疗应用中的重要诊断和手术工具。对标靶疾病检测和治疗的需求不断增长,推动了对萤光内视镜的需求。这项创新技术使医疗保健专业人员能够更精确地可视化特定组织和异常情况,从而实现准确诊断和有针对性的干预。此外,萤光内视镜在生物科学中发挥重要作用,特别是在次世代定序仪应用中。研究人员越来越多地利用内视镜萤光方法来促进基因序列的可视化和分析,从而推动基因组学和个人化医疗的进步。然而,与萤光内视镜检查相关的程序通常昂贵且耗时,这主要是由于需要专门的设备和专业知识。这些成本和时间因素是采用的障碍,特别是在资源有限的医疗保健环境中。然而,儘管存在这些挑战,对微创诊断和外科手术的渴望、持续的技术改进以及不断增加的研究和开发都在推动萤光内视镜市场的扩张。随着医疗保健产业不断认识到萤光内视镜检查的好处,人们正在努力解决成本和时间问题、改善安全措施并提高这些程序的整体效率。萤光内视镜有可能彻底改变诊断和治疗性介入,并将在未来的医学影像和精准医学中发挥关键作用。
主要市场统计 | |
---|---|
基准年[2023] | 81.1亿美元 |
预测年份 [2024] | 87.2亿美元 |
预测年份 [2030] | 138.2亿美元 |
复合年增长率(%) | 7.90% |
增加配件的使用,提高产品的耐用度和精度
光源、滤光片和显影剂配件对于增强萤光内视镜的功能至关重要。诊所和医院根据手术的复杂性和内视镜设备的能力优先考虑其使用。高端配件耐用且精确,但对于小型诊所或门诊中心来说可能不划算。偏好通常与手术类型和患者周转率一致。内视镜检查是利用萤光内视镜进行医疗的中心。内视镜的选择通常基于影像解析度、景深和特定应用领域(例如胃肠病学或呼吸系统医疗设备)。内视镜有多种类型,包括软性内视镜和硬性内视镜,每种内视镜都有各自的优点。软式内视镜是首选,因为它们可以轻鬆地穿过体内的弯曲途径,而硬式内视镜在可触及区域提供更好的影像品质。成像系统的选择是基于其与现有内视镜设备整合的能力、可检测的萤光类型以及增强影像分析和储存的软体功能。
焦点:更多采用电动萤光内视镜系统,提供自动化和易用性
电动萤光内视镜系统采用先进技术来增强医疗手术过程中组织和细胞的可视化。它们通常具有缩放、聚焦和滤镜选择等自动化功能,只需按一下按钮即可进行调整。这些系统专为那些要求诊断和治疗性介入准确、高效和弹性的医生而设计。手动萤光内视镜系统涉及更实际的方法,依赖操作内视镜的医务人员的技能和天赋。这些系统需要手动调整萤光过程中使用的滤光片和光源。
应用:检查肺部和气道的肺内视镜检查变得越来越重要。
在关节镜中,使用内视镜检查和治疗关节内部。关节镜中的萤光内视镜有助于执行微创手术来诊断和治疗关节疾病,包括关节炎。支气管镜检查是指一种内视镜技术,可观察气道内部以进行诊断和治疗。耳鼻喉镜用于检查和治疗耳、鼻、喉疾病。使用萤光,内视镜医生可以更好地识别这些区域内的病理情况。胃肠道萤光内视镜检查增强了黏膜异常和癌性病变的检测。在妇产科中,萤光内视镜主要用于腹腔镜手术。可用于子宫内膜异位症等的诊断和治疗。肺内视镜检查与支气管镜检查一样,检查肺部和气道。萤光内视镜检查通常用于发现和切片检查疑似癌变的病变。泌尿系统镜检查包括膀胱镜检查,可观察膀胱和尿道。使用萤光,临床医生可以检测、诊断和量化膀胱癌等疾病。
最终使用者:由于执行的手术范围广泛,医院和诊所将越来越多地引入萤光内视镜检查。
门诊手术中心 (ASC) 是提供当天手术治疗(包括诊断和预防程序)的医疗保健机构。 ASC 对萤光内视镜的需求是由微创手术的需求驱动的,微创手术可以实现快速的患者周转、降低感染率和具有成本效益的服务。由于执行的综合程序和对先进诊断能力的需求,医院和诊所是萤光内视镜检查的最大部分。
区域洞察
萤光内视镜是一种快速发展的医学影像处理技术,已在世界各地广受认可。北美医疗基础设施发达,注重技术进步,在萤光内视镜市场占有很大份额。美国在将萤光内视镜引入和整合到各个医疗领域方面处于领先地位。由于领先市场参与企业的存在、强大的研发力度以及慢性病盛行率的上升,区域萤光内视镜市场正在扩大。在微创手术需求不断增长和医学影像技术进步的推动下,欧洲也是萤光内视镜的主要市场之一。德国、英国和法国等国家越来越多地在医院和诊所采用萤光内视镜,重点在于提高诊断准确性和改善病患治疗效果。亚太地区萤光内视镜市场也出现了显着成长。在中国、日本和印度等国家,不断上涨的医疗成本、不断提高的先进诊断技术意识以及不断增加的患者数量正在推动市场扩张。新兴经济体的存在以及对医疗基础设施发展的日益重视为该地区的市场成长提供了充足的机会。
FPNV定位矩阵
FPNV定位矩阵对于评估萤光内视镜市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对萤光内视镜市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.萤光内视镜市场规模及预测如何?
2.萤光内视镜市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.萤光内视镜市场的技术趋势和法规结构是什么?
4.萤光内视镜市场主要厂商的市场占有率是多少?
5.进入萤光内视镜市场的合适型态和策略手段是什么?
[189 Pages Report] The Fluorescence Endoscopy Market size was estimated at USD 8.11 billion in 2023 and expected to reach USD 8.72 billion in 2024, at a CAGR 7.90% to reach USD 13.82 billion by 2030.
Fluorescence endoscopy is a minimally invasive imaging technique used to assess organ health, diagnose disease, and detect tumor cells. Fluorescence endoscopy has emerged as a vital diagnostic and surgical tool in various medical applications, driven by several key factors. The increasing need for targeted disease detection and treatment has fueled the demand for fluorescence endoscopy. This innovative technique allows healthcare professionals to visualize specific tissues and abnormalities with enhanced precision, enabling accurate diagnosis and targeted interventions. Moreover, fluorescence endoscopy has found significant utility in biosciences, particularly next-generation sequencing applications. Researchers are increasingly leveraging fluorescence endoscopy methods to facilitate the visualization and analysis of genetic sequences, leading to advancements in genomics and personalized medicine. However, the procedures associated with fluorescence endoscopy are often expensive and time-consuming, primarily due to the specialized equipment and expertise required. This cost and time factor pose barriers to adoption, especially in resource-constrained healthcare settings. Nevertheless, despite these challenges, the desire for minimally invasive diagnostic and surgical procedures, continued technical improvements, and increased research and development efforts are all driving the market for fluorescence endoscopy to expand. As the healthcare industry continues to recognize the benefits of fluorescence endoscopy, efforts are being made to address the cost and time concerns, improve safety measures, and enhance the overall efficiency of these procedures. With the potential to revolutionize diagnostics and therapeutic interventions, fluorescence endoscopy is poised to play a significant role in the future of medical imaging and precision medicine.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.11 billion |
Estimated Year [2024] | USD 8.72 billion |
Forecast Year [2030] | USD 13.82 billion |
CAGR (%) | 7.90% |
Product: Growing usage of accessories that provide better durability and precision
Accessories, such as light sources, filters, and contrast agents, are pivotal for augmenting the functionality of fluorescence endoscopes. Clinics and hospitals prioritize these depending on the complexity of procedures and the endoscopy unit's capabilities. High-end accessories provide better durability and precision but may not be cost-effective for smaller clinics or outpatient centers. The preference typically aligns with the type of procedures and patient turnover. Endoscopes are central to the practice of fluorescence endoscopy. The selection is typically based on image resolution, depth of field, and the specific area of application, for example, gastroenterology or pulmonology. Endoscopes come in various types, such as flexible and rigid, each with its advantages. Flexible endoscopes may be favored for their ease of navigation through curvilinear paths in the body, while rigid provide better image quality in accessible areas. Imaging systems are selected based on their integration capabilities with existing endoscopic equipment, the types of fluorescence they can detect, and the software features that enhance image analysis and storage.
Focusing: Rising adoption of electric fluorescence endoscopy systems as they offer automation and ease of use
Electric fluorescence endoscopy systems use advanced technology to enhance the visualization of tissues and cells during medical procedures. They typically offer automated features such as zoom, focus, and filter selection that can be adjusted with the push of a button. These systems are designed for doctors who seek precision, efficiency, and flexibility in diagnostics and therapeutic interventions. Manual fluorescence endoscopy systems involve a more hands-on approach, relying on the skill and finesse of the medical professional to manipulate the endoscope. These systems require manual adjustment of the optical filters and light sources used in the fluorescence process.
Application: Increasing significance of pulmonary endoscopy for examining the lungs and air pathways
Arthroscopy involves endoscopic examination and treatment of the interior of a joint. Fluorescence endoscopy in arthroscopy helps in performing minimally invasive procedures to diagnose and treat joint diseases, including arthritis. Bronchoscopy refers to the endoscopic technique of visualizing the inside of the airways for diagnostic and therapeutic purposes. ENT endoscopy is used for examining and treating ear, nose, and throat conditions. Using fluorescence, endoscopists can better identify pathologies within these areas. Fluorescence endoscopy in the gastrointestinal tract enhances the detection of mucosal abnormalities or cancerous lesions. In obstetrics and gynecology, fluorescence endoscopy is predominantly used in laparoscopic procedures. It assists in diagnosing and treating conditions such as endometriosis. Pulmonary endoscopy, similar to bronchoscopy, involves examining the lungs and air pathways. Fluorescence endoscopy is often used to detect and biopsy lesions suspected of cancer. Urology endoscopy includes cystoscopy, which allows for visualization of the bladder and urethra. Using fluorescence, clinicians can detect, diagnose, and quantify diseases such as bladder cancer.
End-User: Expanding deployment of fluorescence endoscopy across hospitals & clinics due to the comprehensive range of procedures performed
Ambulatory surgery centers (ASCs) are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. The need for fluorescence endoscopy in ASCs is driven by the demand for minimally invasive surgeries that allow for quicker patient turnover, reduced infection rates, and cost-effective services. Hospitals & clinics represent the largest segment for fluorescence endoscopy due to the comprehensive range of procedures performed and the need for advanced diagnostic capabilities.
Regional Insights
Fluorescence endoscopy is a rapidly growing medical imaging technology that has gained significant traction worldwide. North America, with its well-established healthcare infrastructure and high emphasis on technological advancements, holds a significant share of the fluorescence endoscopy market. The United States has been at the forefront of adopting and integrating fluorescence endoscopy into various medical specialties. The fluorescence endoscopy market in this region is expanding with the existence of major market participants, strong research and development efforts, and the rising prevalence of chronic diseases. Europe is another prominent market for fluorescence endoscopy, driven by the rising demand for minimally invasive procedures and advancements in medical imaging technologies. Countries such as Germany, the United Kingdom, and France have witnessed widespread adoption of fluorescence endoscopy in hospitals and clinics, focusing on improving diagnostic accuracy and patient outcomes. The Asia-Pacific region is also experiencing significant growth in the fluorescence endoscopy market. Rising healthcare expenditure, increasing awareness about advanced diagnostic techniques, and a large patient population contribute to the expanding market in countries such as China, Japan, and India. The presence of emerging economies and a growing emphasis on healthcare infrastructure development presents ample opportunities for market growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Fluorescence Endoscopy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Fluorescence Endoscopy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Fluorescence Endoscopy Market, highlighting leading vendors and their innovative profiles. These include Adronic Instrument Manufacturing Co., Ltd., AMNOTEC International Medical GmbH, Arthrex, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Carl Zeiss AG, ConMed Corporation, ERBE Elektromedizin GmbH, Haitai Xinguang, Healnoc, Hoya Corporation, Karl Storz SE & Co. KG, Medtronic PLC, Modulight Corp., Nanjing Nuoyuan Medical Devices Co., Ltd., Olympus Corporation, OptoMedic, PENTAX Medical, Richard Wolf GmbH, SCHOLLY FIBEROPTIC GMBH, Scivita Medical Technology Co., Ltd., Smith & Nephew PLC, STERIS Corporation, Stryker Corporation, Suzhou Caring Medical Co., Ltd., and Tuge Medical.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Fluorescence Endoscopy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Fluorescence Endoscopy Market?
3. What are the technology trends and regulatory frameworks in the Fluorescence Endoscopy Market?
4. What is the market share of the leading vendors in the Fluorescence Endoscopy Market?
5. Which modes and strategic moves are suitable for entering the Fluorescence Endoscopy Market?